Wolinsky, E. Non-tuberculous mycobacteria and associated diseases. Am. Rev. Resp. Dis. 119 (1979) 107–159.
Google Scholar
Edwards, L. B., Palmer, C. E. Isolation of atypical mycobacteria from healthy persons. Am. Rev. Resp. Dis. 80 (1959) 747–749.
Google Scholar
Pergament, M., Gonzales, R., Fraley, E. E. Atypical mycobacteria of the urinary tract. A case report of extensive disease caused by theBettey bacillus. JAMA 229 (1974) 816–817.
Google Scholar
Newman, H. Renal disease associated with atypical mycobacteria: balley type. J. Urol. 103 (1970) 403–405.
Google Scholar
Rosen, D. I.
M. fortuitum in the urinary tract. J. Urol. 144 (1975) 915–952.
Google Scholar
Lee, L. W., Burgher, L. W., Price, E. B., Cassidy, D. Granulomatous prostatitis, association with isolation ofMycobacterium kansasii and Mycobacterium fortuitum. JAMA 237 (1977) 2408–2409.
Google Scholar
De Costa, Cruz, J. C.
M. fortuitum un nowo bacilo acido resistence pathogenico para o homen. Acta Med. Rio de Janeiro 1 (1983) 297–301.
Google Scholar
Hoffman, P. C., Fraser, D. W., Robicsek Two outbreaks of sternal wound infections due to organisms of theMycobacterium fortuitum complex. J. Inf. Dis. 143 (1981) 533–542.
Google Scholar
Woods, G. L., Hall, G. S., Schreiber, M. J.
M. fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. J. Clin. Microb. 23 (1986) 786–788.
Google Scholar
Clegg, H. W., Foster, M. T., Sandres, W. E., Baine, W. B. Infection due toM. fortuitum complex after augmentation mammoplasty: clinical and epidemiologye features. J. Infect. Dis. 147 (1983) 427–433.
Google Scholar
Santamaria-Jauregui, J., Sanz-Hospital, J. Brenguer, J., Munoz, D., Gomez-Mampaso, E., Bouza, E. Meningitis caused byM. fortuitum, Am. Rev. Resp. Dis. 130 (1983) 136–137.
Google Scholar
Jennifer, F. H., Rolston, K. V., Hopfer, R. L., Bodey, G. P.
Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. Am. J. Med. 82 (1987) 213–217.
Google Scholar
Swenson, J. A., Wallace, R. J., Silcox, V. A., Thornsberry, C. Antimicrobial suseeptibility of five subgroups ofMycobacterium fortuitum andMycobacterium chelonae. Antimicrob. Agents Chemother. 28 (1985) 807–810.
Google Scholar
Wallace, R. J., Swenson, J. M., Silcox, V. A., Bullen, M. G. Treatment of nonpulmonary infections due toMycobacterium fortuitum andMycobacterium chelonei on the basis of in vitro susceptibilities. J. Infect. Dis. 152 (1985) 500–514.
Google Scholar
Garcia-Rodriguez, J. A. Activity of quinolones against mycobacteria — “in vitro” and “in vivo”. Quinol. Bulletin 4 (1988) 21–25.
Google Scholar
Hass, H., Zuali, R., Sachs, V. Susceptibility ofM. fallax to imipenem and seventy other antimicrobial agents. Eur. J. Clin. Microbiol. 3 (1984) 489–492.
Google Scholar
Casal, M. J., Rodriguez, F. C., Benavente, M. C.
In vitro susceptibility ofMycobacterium fortuitum andMycobacterium chelonei to Cefmetazole. Antimicrob. Agents Chemother. 27 (1985) 282–283.
Google Scholar
Leysen, D. C., Haemers, A., Pattyn, S. R. Mycobacteria and the new quinolones. Antimicrob. Agents Chemother. 33 (1989) 1–5.
Google Scholar